Assessment of Generalized Pain Hypersensitivity in Rheumatoid Arthritis
- Conditions
- Rheumatoid Arthritis / Fibromyalgia
- Registration Number
- NL-OMON21279
- Lead Sponsor
- Medisch Spectrum Twente
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 61
Inclusion Criteria
(1) A signed, written informed consent, (2) Clinical diagnosis of Rheumatoid Arthritis, (3) Patient at the Rheumatology Department of the MST Hospital
Exclusion Criteria
(1) Patient's refusal during the study, (2) Skin problems at one of the sites of the pain sensitivity measurements, (3) Language problems, (4) Diabetes, (5) Small fiber neuropathy, (6) Implanted stimulation device, (7) Pregnancy, (8) Unable to undergo pain sensitivity measurements, (9), Age >70 years old
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method • Evaluation of the 2-week test-retest reliability of the Generalized Pain Questionnaire (GPQ);<br>• Exploration of the effect of pain sensitivity measurements (PPT, EPT and NDT) and questionnaires (CSI, GPQ, SF-36, and PCS) in Rheumatoid Arthritis patients and its relation to the painful-to-swollen joint count ratio;
- Secondary Outcome Measures
Name Time Method • Evaluation of the criterion validity of the GPQ against the pain sensitivity measurements (PPT, EPT and NDT).